LadanEspandarMD
Ophthalmology • Pittsburgh, PACataract Related, Cornea & External Disease
Clinical Associate in the Department of Ophthalmology, Duke University School of Medicine
Dr. Espandar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
203 Lothrop St
7TH floor Eeins
Pittsburgh, PA 15213Phone+1 412-647-2214Fax+1 412-647-0997
Education & Training
Tulane UniversityResidency, Ophthalmology, 2009 - 2012- Tulane UniversityInternship, Transitional Year, 2008 - 2009
Tehran University of Medical Sciences School of MedicineClass of 2000
Certifications & Licensure
PA State Medical License 2014 - 2024
NC State Medical License 2012 - 2015- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK Start of enrollment: 2015 Feb 01
Publications & Presentations
PubMed
- 151 citationsCataract surgery for the developing worldGeoffrey Tabin, Michael C Chen, Ladan Espandar
Current Opinion in Ophthalmology. 2008-01-01 - 30 citationsSuccessful treatment of cancer-associated retinopathy with alemtuzumab.Ladan Espandar, Susan O'Brien, Charles E. Thirkill, Linda Lubecki, Bita Esmaeli
Journal of Neuro-Oncology. 2007-01-25 - 17 citationsUlcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine.Debraj Shome, Jonathan C. Trent, Ladan Espandar, Elham Hatef, Dejka M. Araujo
Ophthalmology. 2008-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
